Structures of segments of α‐synuclein fused to maltose‐binding protein suggest intermediate states during amyloid formation

Aggregates of the protein α‐synuclein are the main component of Lewy bodies, the hallmark of Parkinson's disease. α‐Synuclein aggregates are also found in many human neurodegenerative diseases known as synucleinopathies. In vivo, α‐synuclein associates with membranes and adopts α‐helical conformations. The details of how α‐synuclein converts from the functional native state to amyloid aggregates remain unknown. In this study, we use maltose‐binding protein (MBP) as a carrier to crystallize segments of α‐synuclein. From crystal structures of fusions between MBP and four segments of α‐synuclein, we have been able to trace a virtual model of the first 72 residues of α‐synuclein. Instead of a mostly α‐helical conformation observed in the lipid environment, our crystal structures show α‐helices only at residues 1–13 and 20–34. The remaining segments are extended loops or coils. All of the predicted fiber‐forming segments based on the 3D profile method are in extended conformations. We further show that the MBP fusion proteins with fiber‐forming segments from α‐synuclein can also form fiber‐like nano‐crystals or amyloid‐like fibrils. Our structures suggest intermediate states during amyloid formation of α‐synuclein.

[1]  David Eisenberg,et al.  Molecular mechanisms for protein-encoded inheritance , 2009, Nature Structural &Molecular Biology.

[2]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[3]  Vladimir N. Uversky,et al.  Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation , 2007 .

[4]  J Q Trojanowski,et al.  Synucleinopathies: clinical and pathological implications. , 2001, Archives of neurology.

[5]  Vladimir N Uversky,et al.  A Protein-Chameleon: Conformational Plasticity of α-Synuclein, a Disordered Protein Involved in Neurodegenerative Disorders , 2003, Journal of biomolecular structure & dynamics.

[6]  C. Dobson,et al.  Structure and properties of a complex of α-synuclein and a single-domain camelid antibody. , 2010, Journal of molecular biology.

[7]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[8]  Christian Hansen,et al.  Are synucleinopathies prion-like disorders? , 2010, The Lancet Neurology.

[9]  R. Szargel,et al.  Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Valerie L. Anderson,et al.  Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation , 2010, Proceedings of the National Academy of Sciences.

[11]  D. Baker,et al.  The 3D profile method for identifying fibril-forming segments of proteins. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[13]  M. Goedert,et al.  The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy , 2000 .

[14]  Ad Bax,et al.  Structure and Dynamics of Micelle-bound Human α-Synuclein* , 2005, Journal of Biological Chemistry.

[15]  Robert A. Grothe,et al.  Structure of the cross-beta spine of amyloid-like fibrils. , 2005, Nature.

[16]  Kostas Vekrellis,et al.  Neurobiology of alpha-synuclein. , 2004, Molecular neurobiology.

[17]  David Eisenberg,et al.  Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process , 2009, Protein science : a publication of the Protein Society.

[18]  V. Lee,et al.  Alpha-synuclein: normal function and role in neurodegenerative diseases. , 2004, Current topics in developmental biology.

[19]  P. Lansbury,et al.  The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease? , 1995, Chemistry & biology.

[20]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[21]  Jeannie Chen,et al.  Investigation of alpha-synuclein fibril structure by site-directed spin labeling. , 2007, The Journal of biological chemistry.

[22]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein from site-directed spin labeling and computational refinement , 2008, Proceedings of the National Academy of Sciences.

[23]  Zbyszek Otwinowski,et al.  Secondary structure of Huntingtin amino-terminal region. , 2009, Structure.

[24]  M. Goedert,et al.  The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. , 2000, Annals of the New York Academy of Sciences.

[25]  Thomas C. Südhof,et al.  α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration , 2005, Cell.

[26]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Ralf Langen,et al.  Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .

[28]  Heather T. McFarlane,et al.  Atomic structures of amyloid cross-β spines reveal varied steric zippers , 2007, Nature.

[29]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[30]  S. Lindquist,et al.  α-Synuclein: membrane interactions and toxicity in Parkinson's disease. , 2010, Annual review of cell and developmental biology.

[31]  Ralf Langen,et al.  Structure of membrane-bound alpha-synuclein studied by site-directed spin labeling. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C. Dobson,et al.  Differential Phospholipid Binding of α-Synuclein Variants Implicated in Parkinson’s Disease Revealed by Solution NMR Spectroscopy† , 2009, Biochemistry.

[33]  T. Südhof,et al.  α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro , 2010, Science.

[34]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[35]  Vladimir N Uversky,et al.  Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation. , 2007, Journal of neurochemistry.

[36]  D. Baker,et al.  Native protein sequences are close to optimal for their structures. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  David Eisenberg,et al.  Atomic structures of amyloid cross-beta spines reveal varied steric zippers. , 2007, Nature.

[38]  David Eisenberg,et al.  Identifying the amylome, proteins capable of forming amyloid-like fibrils , 2010, Proceedings of the National Academy of Sciences.

[39]  T. Südhof,et al.  Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. , 2005, Cell.

[40]  L. Petrucelli,et al.  α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.

[41]  R. Burgoyne,et al.  Chaperoning the SNAREs: a role in preventing neurodegeneration? , 2010, Nature Cell Biology.

[42]  Martina Huber,et al.  Direct evidence of coexisting horseshoe and extended helix conformations of membrane-bound alpha-synuclein. , 2011, Chemphyschem : a European journal of chemical physics and physical chemistry.

[43]  L. Silvian,et al.  A synergistic approach to protein crystallization : Combination of a fixed-arm carrier with surface entropy reduction , 2010 .

[44]  L. Serpell,et al.  X-ray diffraction studies of amyloid structure. , 2005, Methods in molecular biology.

[45]  S. Becker,et al.  Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[46]  K. Coffman,et al.  Secondary , 2020, Definitions.

[47]  P. Worley,et al.  Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions. , 1999, Nature genetics.

[48]  Jeannie Chen,et al.  Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling* , 2007, Journal of Biological Chemistry.

[49]  P Choi,et al.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  A. Steven,et al.  Membrane Curvature Induction and Tubulation Are Common Features of Synucleins and Apolipoproteins* , 2010, The Journal of Biological Chemistry.

[51]  L. Golbe Alpha-synuclein and Parkinson's disease. , 2003, Advances in neurology.

[52]  Jack H Freed,et al.  The Lipid-binding Domain of Wild Type and Mutant α-Synuclein , 2010, The Journal of Biological Chemistry.

[53]  P. Worley,et al.  Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.

[54]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[55]  Kostas Vekrellis,et al.  Neurobiology of α-synuclein , 2004, Molecular Neurobiology.

[56]  P. Højrup,et al.  α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.